Antimicrobial Resistance of Diarrheagenic Escherichia coli Isolated from Children under the Age of 5 Years from Ifakara, Tanzania
- 1 December 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (12), 3022-3024
- https://doi.org/10.1128/aac.43.12.3022
Abstract
Diarrhea caused by multidrug-resistant bacteria is an important public health problem among children in developing countries. The prevalence and antimicrobial susceptibility of diarrheagenic Escherichia coli in 346 children under 5 years of age in Ifakara, Tanzania, were studied. Thirty-eight percent of the cases of diarrhea were due to multiresistant enterotoxigenic E. coli , enteroaggregative E. coli , or enteropathogenic E. coli . Strains of all three E. coli categories showed high-level resistance to ampicillin, tetracycline, co-trimoxazole, and chloramphenicol but were highly susceptible to quinolones. Guidelines for appropriate use of antibiotics in developing countries need updating.Keywords
This publication has 9 references indexed in Scilit:
- Prevalence of diarrheagenic Escherichia coli strains detected by PCR in patients with travelers' diarrheaClinical Microbiology & Infection, 1998
- Surveillance of antimicrobial resistance---an international perspectiveBMJ, 1998
- Enteropathogenicity markers in Escherichia coli isolated from infants with acute diarrhoea and healthy controls in Rio de Janeiro, BrazilJournal of Medical Microbiology, 1998
- Enteroaggregative Escherichia coliEmerging Infectious Diseases, 1998
- DiarrheagenicEscherichia coliClinical Microbiology Reviews, 1998
- Multidrug-Resistant Enteroaggregative Escherichia coli Associated with Persistent Diarrhea in Kenyan ChildrenEmerging Infectious Diseases, 1997
- Mortality by cause for eight regions of the world: Global Burden of Disease StudyThe Lancet, 1997
- An Open, Controlled Study of Two Non-absorbable Antibiotics for the Oral Treatment of Paediatric Infectious DiarrhoeaCurrent Medical Research and Opinion, 1997
- Treatment of Experimentally Induced Enterotoxigenic Escherichia coli Diarrhea with Trimethoprim, Trimethoprim-Sulfamethoxazole, or PlaceboClinical Infectious Diseases, 1982